SII Covovax gets DCGI emergency use nod for 12 to 18 year olds Ruchika Sharma24 March 2022 12:09 PM ISTCovovax is the fourth vaccine to receive EUA from DCGI for use among adolescents 12 and older.
CDSCO SEC okays Covovax for 12-17 year-olds Medical Dialogues Bureau6 March 2022 5:06 PM ISTNew Delhi: The Subject Expert Committee (SEC) has recommended granting emergency use authorisation (EUA) to Serum India of India's COVID-19 vaccine...
Serum Institute seeks DCGI approval for phase 3 trial of Covovax as booster dose MD Bureau28 Feb 2022 12:35 PM ISTCovovax is approved by the European Medicines Agency for conditional marketing authorisation and also granted emergency use listing by WHO.
Heath Bulletin 8/February/2022 Roshni Dhar8 Feb 2022 5:38 PM ISTHere are Top health stories of the daySchools, colleges reopen in Delhi, 4 other states as covid cases drop Kerala based Hepatologist lands in soup...
SII proposal to manufacture Omicron vaccine for analysis gets DCGI nod Ruchika Sharma8 Feb 2022 12:06 PM ISTNew Delhi: The Drugs Controller General of India (DCGI) has approved Serum Institute of India's proposal to manufacture a vaccine against omicron...
Reduce gap between doses of Covishield : Serum Institute urges Mansukh Mandaviya Ruchika Sharma4 Feb 2022 3:22 PM ISTThe Serum Institute of India have urged the govt to reduce the gap between the second and third precautionary doses of COVID vaccine from 9 months to...
Doctor Died allegedly after Covishield Jab, father seeks Rs 1000 crore in Court Plea Adity Saha3 Feb 2022 12:26 PM ISTMumbai: Following the death of a 33 year old senior lecturer in a nagpur medical college who diedon 1st March 2021, her father has now filed an...
DCGI regular market nod to Covaxin, Covishield for adults Ruchika Sharma28 Jan 2022 12:06 PM ISTNew Delhi: India's drug regulator Drugs Controller General of India's (DCGI) on Thursday granted regular market approval for Covid-19 vaccines...
Covid-19: Covaxin, Covishield prices likely to be capped at Rs 275 per dose Ruchika Sharma27 Jan 2022 12:15 PM ISTNew Delhi: The price of Covishield and Covaxin, the Covid vaccines which are expected to soon get regular market approval from India's drug regulator,...
Covishield, Covaxin get regular market approval MD Bureau20 Jan 2022 4:39 PM ISTNew Delhi: India's two main vaccines, Bharat Biotech's Covaxin and Serum Institute of India's Covishield, on Wednesday got the nod for regular market...
Novavax files data with USFDA to back COVID vaccine Ruchika Sharma1 Jan 2022 10:00 AM ISTGaithersburg: Novavax, Inc. has announced that the company has completed submission of the final data package, including the complete chemistry,...
Covovax nod to strengthen immunization efforts in India: SII Roshni Dhar31 Dec 2021 10:30 AM ISTVaccine major serum institute of India (SII) on Tuesday said the approval for the covid-19 vaccine 'covovax' would strength immunization across India...
